In a study, the RNA-encoded viral nucleic acid analytic reporter correctly determined the Alpha, Gamma, Delta, Epsilon, and Omicron genetic mutations in nasopharyngeal clinical samples.
“The COVID-19 pandemic has created an urgent need for individualized diagnostic tools that can recognize the presence of the virus as well as the particular strain,” says corresponding author John Chaput, professor of pharmaceutical sciences at the University of California, Irvine.
Read the full story here.